SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-004262
Filing Date
2024-01-18
Accepted
2024-01-17 20:37:18
Documents
1
Group Members
STEPHEN L. GUSTIN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea191783-13ga1explor_fresh.htm SC 13G/A 50421
  Complete submission text file 0001213900-24-004262.txt   52254
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Subject) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42755 | Film No.: 24539886
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111
Business Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111 (212) 220-4444
Exploration Capital, LLC (Filed by) CIK: 0002003514 (see all company filings)

IRS No.: 843905486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A